AcrAB-TolC Efflux Pump System Plays a Role in Carbapenem Non-susceptibility in Escherichia Coli

Overview

Journal BMC Microbiol

Publisher Biomed Central

Specialty Microbiology

Date 2019 Sep 7

PMID 31488061

Citations 38

Authors

Shiela Chetri

Deepshikha Bhowmik

Deepjyoti Paul

Piyush Pandey

Debadatta Dhar Chanda

Atanu Chakravarty

Debajyoti Bora

Amitabha Bhattacharjee

Affiliations

Soon will be listed here.

Abstract

Background: Efflux pump mediated antibiotic resistance is an unnoticed and undetected mechanism in clinical microbiology laboratory. RND efflux systems are known for aminoglycoside and tetracycline resistance whereas their role in carbapenem non-susceptibility is not established. The study was undertaken to investigate the role of efflux pump in providing resistance against carbapenems and their response against concentration gradient carbapenem stress on the transcriptional level of the AcrAB gene in the clinical isolates of Escherichia coli from a tertiary referral hospital of Northeast India.

Results: Out of 298 non-susceptible Escherichia coli isolates 98 isolates were found to have efflux pump mediated carbapenem non-susceptibility. Among them thirty-five were non carbapenemase producers and their expressional levels were verified using qRT-PCR under concentration gradient carbapenem stress. In this study, a strong correlation between ertapenem resistance and AcrA overexpression was observed which has not been reported previously. Further, it was observed that imipenem stress increased AcrB expression in Escherichia coli which holds the novelty of this study. Additionally, the transcription of AcrR was insistently increased which is much higher than the transcriptional level of AcrA under concentration gradient carbapenem stress condition.

Conclusion: The study established that AcrAB pump is a relevant antibiotic resistance determinant in bacterial pathogen, has an important role in developing resistance against carbapenem group of antibiotics.

Citing Articles

Virulence genes, efflux pumps, and molecular typing of Klebsiella pneumoniae isolates from North Iran.

Birgani A, Goli H, Siadat S, Fateh A, Nikbin V, Sakhaee F AMB Express. 2025; 15(1):36.

PMID: 40045145 PMC: 11883068. DOI: 10.1186/s13568-025-01845-1.

High Prevalence of Antimicrobial Resistance Genes in Multidrug-Resistant Extended-Spectrum Beta-Lactamase-Producing Clinical Isolates after COVID-19 Pandemic, North Iran.

Rahimzadeh G, Rezai S, Valadan R, Rezai R, Soleimanpour S, Vahedi L Adv Biomed Res. 2024; 13:105.

PMID: 39717239 PMC: 11665164. DOI: 10.4103/abr.abr_341_24.

Antibacterial and Anti-biofilm Effects of Thymoquinone Against Carbapenem-Resistant Uropathogenic .

Jin H, Eom Y Indian J Microbiol. 2024; 64(4):1747-1756.

PMID: 39678958 PMC: 11645355. DOI: 10.1007/s12088-024-01231-8.

Multidrug-Resistant Urinary Tract Infections in Pregnant Patients and Their Association with Adverse Pregnancy Outcomes-A Retrospective Study.

Anton G, Gheorghe L, Radu V, Scripcariu I, Vasilache I, Carauleanu A J Clin Med. 2024; 13(22).

PMID: 39597809 PMC: 11595148. DOI: 10.3390/jcm13226664.

Risk factors and molecular characterization of carbapenem resistant Escherichia coli recovered from a tertiary hospital in Fujian, China from 2021 to 2023.

Lian S, Liu C, Cai M, Cao Y, Xu X BMC Microbiol. 2024; 24(1):374.

PMID: 39342086 PMC: 11438195. DOI: 10.1186/s12866-024-03525-9.

References

Rosenberg E, Ma D, Nikaido H . AcrD of Escherichia coli is an aminoglycoside efflux pump. J Bacteriol. 2000; 182(6):1754-6. PMC: 94475. DOI: 10.1128/JB.182.6.1754-1756.2000. View

Zgurskaya H, Nikaido H . Multidrug resistance mechanisms: drug efflux across two membranes. Mol Microbiol. 2000; 37(2):219-25. DOI: 10.1046/j.1365-2958.2000.01926.x. View

Woo P, Leung P, Leung K, Yuen K . Identification by 16S ribosomal RNA gene sequencing of an Enterobacteriaceae species from a bone marrow transplant recipient. Mol Pathol. 2000; 53(4):211-5. PMC: 1186972. DOI: 10.1136/mp.53.4.211. View

Yigit H, Queenan A, Anderson G, Domenech-Sanchez A, Biddle J, Steward C . Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001; 45(4):1151-61. PMC: 90438. DOI: 10.1128/AAC.45.4.1151-1161.2001. View

Yum J, Yi K, Lee H, Yong D, Lee K, Kim J . Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla(VIM-2) gene cassettes. J Antimicrob Chemother. 2002; 49(5):837-40. DOI: 10.1093/jac/dkf043. View

Elkins C, Nikaido H . Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominantly by two large periplasmic loops. J Bacteriol. 2002; 184(23):6490-8. PMC: 135441. DOI: 10.1128/JB.184.23.6490-6499.2002. View

Bornet C, Chollet R, Mallea M, Chevalier J, Davin-Regli A, Pages J . Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes. Biochem Biophys Res Commun. 2003; 301(4):985-90. DOI: 10.1016/s0006-291x(03)00074-3. View

Quale J, Bratu S, Landman D, Heddurshetti R . Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis. 2003; 37(2):214-20. DOI: 10.1086/375821. View

Mallea M, Mahamoud A, Chevalier J, Alibert-Franco S, Brouant P, Barbe J . Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates. Biochem J. 2003; 376(Pt 3):801-5. PMC: 1223807. DOI: 10.1042/BJ20030963. View

10.

Weinreich D, Delaney N, DePristo M, Hartl D . Darwinian evolution can follow only very few mutational paths to fitter proteins. Science. 2006; 312(5770):111-4. DOI: 10.1126/science.1123539. View

11.

Piddock L . Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol. 2006; 4(8):629-36. DOI: 10.1038/nrmicro1464. View

12.

Mendes R, Bell J, Turnidge J, Castanheira M, Jones R . Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother. 2008; 63(1):55-9. DOI: 10.1093/jac/dkn434. View

13.

Lozovsky E, Chookajorn T, Brown K, Imwong M, Shaw P, Kamchonwongpaisan S . Stepwise acquisition of pyrimethamine resistance in the malaria parasite. Proc Natl Acad Sci U S A. 2009; 106(29):12025-30. PMC: 2715478. DOI: 10.1073/pnas.0905922106. View

14.

Yong D, Toleman M, Giske C, Cho H, Sundman K, Lee K . Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009; 53(12):5046-54. PMC: 2786356. DOI: 10.1128/AAC.00774-09. View

15.

Andersson D, Hughes D . Antibiotic resistance and its cost: is it possible to reverse resistance?. Nat Rev Microbiol. 2010; 8(4):260-71. DOI: 10.1038/nrmicro2319. View

16.

Takatsuka Y, Chen C, Nikaido H . Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli. Proc Natl Acad Sci U S A. 2010; 107(15):6559-65. PMC: 2872455. DOI: 10.1073/pnas.1001460107. View

17.

Swick M, Morgan-Linnell S, Carlson K, Zechiedrich L . Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance. Antimicrob Agents Chemother. 2010; 55(2):921-4. PMC: 3028778. DOI: 10.1128/AAC.00996-10. View

18.

Nikaido H, Pages J . Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol Rev. 2011; 36(2):340-63. PMC: 3546547. DOI: 10.1111/j.1574-6976.2011.00290.x. View

19.

Toprak E, Veres A, Michel J, Chait R, Hartl D, Kishony R . Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat Genet. 2011; 44(1):101-5. PMC: 3534735. DOI: 10.1038/ng.1034. View

20.

Fernandez L, Hancock R . Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev. 2012; 25(4):661-81. PMC: 3485749. DOI: 10.1128/CMR.00043-12. View